The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Yi Kathy since 2018.
The trader's CIK number is 1697802.
At the time of the last reporting, Yi Kathy was the SVP & Chief Financial Officer of Sangamo Therapeutics, Inc. (stock ticker symbol SGMO).
Also see all insider trading activities at Sangamo Therapeutics, Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | SGMO | 0 | $0 | 25,000 | $265,749 | 25,000 | $113,750 |
| 2018 | SGMO | 0 | $0 | 50,000 | $783,385 | 50,000 | $227,500 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-05-15 | SGMO | Option Ex | 5,000 | 4.55 | 22,750 |
| 2019-05-15 | SGMO | Sale | 5,000 | 10.00 | 50,000 |
| 2019-04-15 | SGMO | Option Ex | 5,000 | 4.55 | 22,750 |
| 2019-04-15 | SGMO | Sale | 5,000 | 12.11 | 60,550 |
| 2019-03-15 | SGMO | Option Ex | 5,000 | 4.55 | 22,750 |
| 2019-03-15 | SGMO | Sale | 5,000 | 10.00 | 50,000 |
| 2019-03-01 | SGMO | Option Ex | 5,000 | 4.55 | 22,750 |
| 2019-03-01 | SGMO | Sale | 5,000 | 10.00 | 50,000 |
| 2019-01-15 | SGMO | Option Ex | 5,000 | 4.55 | 22,750 |
| 2019-01-15 | SGMO | Sale | 5,000 | 11.04 | 55,199 |
| 2018-12-17 | SGMO | Option Ex | 5,000 | 4.55 | 22,750 |
| 2018-12-17 | SGMO | Sale | 5,000 | 11.44 | 57,200 |
| 2018-11-15 | SGMO | Option Ex | 5,000 | 4.55 | 22,750 |
| 2018-11-15 | SGMO | Sale | 5,000 | 10.00 | 50,000 |
| 2018-10-15 | SGMO | Sale | 5,000 | 13.97 | 69,850 |
| 2018-10-15 | SGMO | Option Ex | 5,000 | 4.55 | 22,750 |
| 2018-09-17 | SGMO | Option Ex | 5,000 | 4.55 | 22,750 |
| 2018-09-17 | SGMO | Sale | 5,000 | 14.66 | 73,285 |
| 2018-08-16 | SGMO | Option Ex | 5,000 | 4.55 | 22,750 |
| 2018-08-16 | SGMO | Sale | 5,000 | 15.39 | 76,950 |
| 2018-07-16 | SGMO | Option Ex | 5,000 | 4.55 | 22,750 |
| 2018-07-16 | SGMO | Sale | 5,000 | 14.77 | 73,860 |
| 2018-06-15 | SGMO | Sale | 5,000 | 15.67 | 78,365 |
| 2018-06-15 | SGMO | Option Ex | 5,000 | 4.55 | 22,750 |
| 2018-05-15 | SGMO | Sale | 5,000 | 15.38 | 76,920 |
| 2018-05-15 | SGMO | Option Ex | 5,000 | 4.55 | 22,750 |
| 2018-04-16 | SGMO | Option Ex | 5,000 | 4.55 | 22,750 |
| 2018-04-16 | SGMO | Sale | 5,000 | 19.83 | 99,145 |
| 2018-03-15 | SGMO | Option Ex | 5,000 | 4.55 | 22,750 |
| 2018-03-15 | SGMO | Sale | 5,000 | 25.56 | 127,810 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Yi Kathy (SVP & Chief Financial Officer of Sangamo Therapeutics, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.